
Sari Safaa Khaleel MD MD, MSc
Surgical Oncology
Assistant Professor of Urology, Brown University; Brown Urology Inc
Join to View Full Profile
195 Collyer StProvidence, RI 02904
Phone+1 401-272-7799
Dr. Khaleel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sari Khaleel is a urologic oncologist affiliated with Brown Urology Inc and Lifespan Inc. He specializes in urologic surgical oncology and is experienced in prostate cancer, kidney cancer, bladder cancer, and testicular cancer. He has more than 10 publications and over 200 citings.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2021 - 2023
- University of MinnesotaResidency, Urology, 2016 - 2021
- Geisel School of Medicine at DartmouthClass of 2016
- University of DelawareMSc, Genomics and Bioinformatics, Magna Cum Laude, 2010 - 2012
- Georgetown CollegeBSc, Biology and Computer Science (Double Major), Magna Cum Laude, 2007 - 2010
Certifications & Licensure
- RI State Medical License 2023 - 2026
- NY State Medical License 2020 - 2023
- MN State Medical License 2017 - 2021
Publications & Presentations
PubMed
- Adrenal Metastasis Ablation in Oligometastatic Renal Cell Carcinoma: A Case Series.Anna Ochsner, Kamil Malshy, Borivoj Golijanin, Anthony Mega, Scott Collins
Clinical Genitourinary Cancer. 2025-04-01 - 1 citationsClinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.Jennifer Ma, Luke Del Balzo, Henry Walch, Sari Khaleel, Andrea Knezevic
European Urology Oncology. 2025-04-01 - 2 citationsGene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors.Sari Khaleel, Marlon Perera, Nathan Papa, Fengshen Kuo, Mahdi Golkaram
Urologic Oncology. 2025-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: